Literature DB >> 11941303

Primary immunodeficiency disorders: antibody deficiency.

Mark Ballow1.   

Abstract

As a group, antibody deficiencies represent the most common types of primary immune deficiencies in human subjects. Often symptoms do not appear until the latter part of the first year of life, as passively acquired IgG from the mother decreases to below protective levels. As with the T-cell immune deficiencies, the spectrum of antibody deficiencies is broad, ranging from the most severe type of antibody deficiency with totally absent B cells and serum Igs to patients who have a selective antibody deficiency with normal serum Ig. In addition to the increased susceptibility to infections, a number of other disease processes (eg, autoimmunity and malignancies) can be involved in the clinical presentation. Fortunately, the availability of intravenous immune serum globulin has made the management of these patients more complete. Recently, molecular immunology has led to identification of the gene or genes involved in many of these antibody deficiencies. As discussed in this review, this has led to a better elucidation of the B-cell development and differentiation pathways and a more complete understanding of the pathogenesis of many of these antibody deficiencies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11941303     DOI: 10.1067/mai.2002.122466

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  52 in total

1.  Work factors as predictors of sickness absence attributed to airway infections; a three month prospective study of nurses' aides.

Authors:  W Eriksen; D Bruusgaard; S Knardahl
Journal:  Occup Environ Med       Date:  2004-01       Impact factor: 4.402

2.  Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.

Authors:  Benjamin M Fiebiger; Jad Maamary; Andrew Pincetic; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L.

Authors:  Zaheed Husain; Nichol Holodick; Caitlin Day; Irma Szymanski; Chester A Alper
Journal:  J Clin Immunol       Date:  2006-04-26       Impact factor: 8.317

4.  Chronic Giardiasis in a Case of Common Variable Immunodeficiency (CVID): A Case Report.

Authors:  Supriya M Paranjpe; Avani Koticha; Preeti R Mehta
Journal:  J Clin Diagn Res       Date:  2016-07-01

5.  Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists.

Authors:  E de Vries
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

6.  Immune globulin intravenous (human), 5% liquid gammaplex: for replacement therapy of primary humoral immunodeficiency.

Authors: 
Journal:  P T       Date:  2011-06

7.  Privigen immune globulin intravenous (human), 10% liquid.

Authors: 
Journal:  P T       Date:  2011-08

8.  Immunoglobulin replacement therapy in antibody deficiency syndromes: are we really doing enough?

Authors:  U Baumann; S Miescher; C Vonarburg
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

9.  Antibody response to pneumococcal vaccination as a function of preimmunization titer.

Authors:  Nathaniel D Hare; Brian J Smith; Zuhair K Ballas
Journal:  J Allergy Clin Immunol       Date:  2008-10-25       Impact factor: 10.793

10.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.